Walking is one of the simplest daily activities, yet for many heart patients it can become unexpectedly difficult.
A short walk to the nearby shop may cause fatigue. Climbing stairs may require several pauses. Some patients experience chest discomfort, breathlessness, or weakness after only a few minutes of movement.
When this happens repeatedly, people often begin avoiding physical activity. They walk less, stay indoors more, and depend increasingly on others for routine tasks. Over time, reduced activity can further weaken stamina and affect confidence, independence, and quality of life.
Enhanced External Counterpulsation, commonly called EECP, is a non-invasive treatment that may help improve exercise tolerance and walking capacity in selected patients with chronic or refractory angina.
However, EECP is not suitable for every heart patient. Its role depends on the person’s diagnosis, symptoms, overall health, and cardiac evaluation.
Walking requires the heart to pump more oxygen-rich blood to the muscles.
When blood flow to the heart is reduced, physical activity may place extra demand on the cardiovascular system. This can lead to symptoms such as:
Some patients may be able to walk comfortably at rest or at a slow pace but develop symptoms when they increase speed, climb an incline, or walk for longer.
As these symptoms continue, patients may gradually reduce their activity. This can create a cycle in which reduced movement causes further loss of physical conditioning.
EECP is a non-surgical treatment performed while the patient lies comfortably on a treatment bed.
Special inflatable cuffs are wrapped around the calves, thighs, and lower body. These cuffs inflate and deflate in coordination with the heartbeat.
The inflation occurs when the heart is resting between beats. This helps push blood from the lower body toward the heart. The cuffs then release just before the heart pumps again.
The treatment is designed to support blood circulation and reduce the workload placed on the heart.
A standard EECP programme often involves approximately 35 one-hour sessions delivered over several weeks. The exact schedule may vary according to the patient’s condition and the treating doctor’s recommendation.
EECP does not involve:
Patients remain awake throughout the session.
Research involving patients with refractory angina has reported improvements in six-minute walking distance following a full course of EECP.
One study involving 47 patients found that average six-minute walking distance increased after 35 EECP sessions, with benefits still observed at the one-year follow-up.
Another study involving 50 patients reported an average walking-distance improvement of 46 metres after EECP, along with reduced angina symptoms and better quality of life.
A more recent retrospective study of 116 patients also reported improvements in six-minute walking distance, exertional angina, and breathlessness after treatment.
These findings suggest that EECP may help some appropriately selected patients walk for longer periods before experiencing fatigue, chest discomfort, or breathlessness.
However, the amount of improvement varies. EECP should not be presented as a guaranteed way to increase stamina in every person with heart disease.
EECP may support walking capacity through several possible effects.
The timed compression of the legs may help increase blood flow toward the heart during the resting phase of the heartbeat.
Better circulation may allow the heart muscle to receive more oxygen-rich blood, particularly during physical activity.
Patients with chronic angina may avoid walking because they are worried about chest discomfort.
If EECP reduces the frequency or intensity of angina in an eligible patient, that person may be able to remain active for longer before symptoms begin.
Some studies have reported longer exercise duration and better functional performance after EECP treatment.
This does not mean EECP acts like physical exercise. Instead, improved symptom control may help the patient gradually take part in more walking or medically supervised rehabilitation.
Some patients report less breathlessness during walking after completing treatment.
This may make routine activities feel more manageable, although breathlessness can have many causes and must be properly evaluated.
Repeated chest pain can make patients afraid to exercise.
When symptoms are better controlled, they may regain confidence in performing simple activities such as walking outdoors, shopping, or climbing stairs.
Improvement does not always mean running, exercising intensely, or walking several kilometres.
For a heart patient, improved stamina may mean:
These small improvements can make a meaningful difference in daily life.
Doctors may use several methods to assess whether a patient’s functional capacity is improving.
The patient is asked to walk as far as comfortably possible for six minutes in a controlled environment.
The medical team records:
The test may be performed before and after an EECP programme to compare progress.
In selected patients, doctors may use treadmill testing or another supervised exercise assessment.
Doctors may ask how often the patient experiences chest pain, breathlessness, or fatigue during routine activities.
Daily independence, emotional confidence, and ability to perform normal tasks may also be considered.
EECP is most commonly considered for selected patients with chronic stable or refractory angina.
Refractory angina generally refers to persistent symptoms that:
Current cardiac guidelines recognise that evidence for EECP is more limited than for standard medicines and revascularisation procedures. It may be considered in selected patients rather than used routinely for everyone with coronary disease.
A cardiologist may evaluate:
No.
Reduced stamina can occur for many reasons besides reduced coronary blood flow.
Possible causes include:
A patient should therefore not begin EECP simply because walking feels difficult.
The cause of the reduced stamina must first be identified through medical evaluation.
Certain conditions may make EECP unsuitable or require additional medical caution.
These may include:
Eligibility must always be determined by a qualified medical team.
EECP does not remove or physically open blocked coronary arteries.
Angioplasty and bypass surgery are established procedures used when they are clinically necessary and appropriate.
EECP may be considered for selected patients whose symptoms continue despite medicines or who are not suitable candidates for further invasive treatment.
The correct option depends on:
Patients should never delay recommended emergency or invasive treatment while waiting to try EECP.
No.
EECP and cardiac rehabilitation have different roles.
Cardiac rehabilitation may include:
EECP may help reduce symptoms in selected patients, potentially allowing them to participate more comfortably in medically approved activity.
Any increase in walking should be gradual and guided by the treating doctor or rehabilitation team.
The heart is not particularly impressed by sudden bursts of heroic enthusiasm after months of inactivity.
Some patients may notice changes during the EECP programme, while others may experience improvement only after completing more sessions.
Possible changes include:
Results vary based on the severity of the disease, general health, physical conditioning, and response to treatment.
Not every patient responds to EECP, and improvement should be measured rather than assumed.
EECP is only one part of long-term heart care.
Patients should continue to follow their medical plan, including:
Stopping medication or ignoring lifestyle recommendations because symptoms have improved can place the patient at risk.
Seek immediate medical attention when chest pain or breathlessness is:
EECP is a planned treatment for selected chronic conditions. It is not an emergency treatment for a heart attack or unstable chest pain.
EECP may improve walking distance, exercise tolerance, angina symptoms, and daily functional capacity in some patients with chronic or refractory angina.
The available evidence includes encouraging results, but much of it comes from relatively small or observational studies. Larger controlled research is still needed, and clinical guidelines do not recommend EECP as a routine treatment for every heart patient.
The most important step is a complete cardiac assessment.
A treatment should be selected because it is appropriate for the patient’s condition, not simply because it is non-invasive.
If chest discomfort, breathlessness, or reduced stamina is limiting your daily life, Oxymed Hospital can help you understand the underlying cause and explore suitable treatment options.
Oxymed Hospital provides medically supervised EECP treatment for eligible patients as part of a personalised cardiac-care approach.
The medical team evaluates each patient’s symptoms, health history, previous procedures, medications, and cardiac condition before recommending treatment.
Consult Oxymed Hospital to learn whether EECP may be appropriate for improving walking capacity, managing chronic angina symptoms, and supporting a safer return to everyday activity.
This article is for general educational purposes and does not replace consultation with a cardiologist. Treatment eligibility and outcomes vary between patients.